| 
                                    
                                    CHEMICAL IDENTIFICATION
 
  RTECS NUMBER :
 
  NK6125000
  
 
  CHEMICAL NAME :
 
  1,3-Indandione, 2-phenyl-
  
 
  CAS REGISTRY NUMBER :
 
  83-12-5
  
 
  LAST UPDATED :
 
  199512
  
 
  DATA ITEMS CITED :
 
  12
  
 
  MOLECULAR FORMULA :
 
  C15-H10-O2
  
 
  MOLECULAR WEIGHT :
 
  222.25
  
 
  WISWESSER LINE NOTATION :
 
  L56 BV DV CHJ CR
  HEALTH HAZARD DATAACUTE TOXICITY DATA
 
  TYPE OF TEST :
 
  TDLo - Lowest published toxic dose
  
 
  ROUTE OF EXPOSURE :
 
  Oral
  
 
  SPECIES OBSERVED :
 
  Human - man
  
 
  DOSE/DURATION :
 
  42500 ug/kg/17D-I
  
 
  TOXIC EFFECTS :
 
  Kidney, Ureter, Bladder - interstitial nephritis Kidney, Ureter, Bladder - urine volume decreased
  
 
  REFERENCE :
 
  BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,1655,1963
  
 
  TYPE OF TEST :
 
  LDLo - Lowest published lethal dose
  
 
  ROUTE OF EXPOSURE :
 
  Oral
  
 
  SPECIES OBSERVED :
 
  Human - man
  
 
  DOSE/DURATION :
 
  48 mg/kg/27D-I
  
 
  TOXIC EFFECTS :
 
  Blood - other changes Nutritional and Gross Metabolic - body temperature increase
  
 
  REFERENCE :
 
  NZMJAX New Zealand Medical Journal. (New Zealand Medical Assoc., P.O. Box 156, Wellington, New Zealand) V.1- 1900- Volume(issue)/page/year: 57,283,1958
  
 
  TYPE OF TEST :
 
  TDLo - Lowest published toxic dose
  
 
  ROUTE OF EXPOSURE :
 
  Unreported
  
 
  SPECIES OBSERVED :
 
  Human - man
  
 
  DOSE/DURATION :
 
  22 mg/kg/17D-I
  
 
  TOXIC EFFECTS :
 
  Liver - hepatitis (hepatocellular necrosis), diffuse Kidney, Ureter, Bladder - interstitial nephritis Skin and Appendages - dermatitis, other (after systemic exposure)
  
 
  REFERENCE :
 
  AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year: 52,706,1960
  
 
  TYPE OF TEST :
 
  TDLo - Lowest published toxic dose
  
 
  ROUTE OF EXPOSURE :
 
  Unreported
  
 
  SPECIES OBSERVED :
 
  Human - man
  
 
  DOSE/DURATION :
 
  90 mg/kg/27D-I
  
 
  TOXIC EFFECTS :
 
  Liver - hepatitis (hepatocellular necrosis), diffuse Skin and Appendages - dermatitis, allergic (after systemic exposure)
  
 
  REFERENCE :
 
  CMAJAX Canadian Medical Association Journal. (Canadian Medical Assoc., POB 8650, Ottawa, ON K1G 0G8, Canada) V.1- 1911- Volume(issue)/page/year: 77,1028,1957
  
 
  TYPE OF TEST :
 
  LDLo - Lowest published lethal dose
  
 
  ROUTE OF EXPOSURE :
 
  Unreported
  
 
  SPECIES OBSERVED :
 
  Human - man
  
 
  DOSE/DURATION :
 
  1683 mg/kg/31D-I
  
 
  TOXIC EFFECTS :
 
  Gastrointestinal - nausea or vomiting Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Skin and Appendages - dermatitis, other (after systemic exposure)
  
 
  REFERENCE :
 
  LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 1,920,1963
  
 
  TYPE OF TEST :
 
  LD50 - Lethal dose, 50 percent kill
  
 
  ROUTE OF EXPOSURE :
 
  Oral
  
 
  SPECIES OBSERVED :
 
  Rodent - rat
  
 
  DOSE/DURATION :
 
  163 mg/kg
  
 
  TOXIC EFFECTS :
 
  Details of toxic effects not reported other than lethal dose value
  
 
  REFERENCE :
 
  EJMCA5 European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- Volume(issue)/page/year: 9,519,1974
  
 
  TYPE OF TEST :
 
  LD50 - Lethal dose, 50 percent kill
  
 
  ROUTE OF EXPOSURE :
 
  Intraperitoneal
  
 
  SPECIES OBSERVED :
 
  Rodent - rat
  
 
  DOSE/DURATION :
 
  190 mg/kg
  
 
  TOXIC EFFECTS :
 
  Behavioral - rigidity (including catalepsy) Behavioral - muscle contraction or spasticity
  
 
  REFERENCE :
 
  THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 16,34,1961
  
 
  TYPE OF TEST :
 
  LD50 - Lethal dose, 50 percent kill
  
 
  ROUTE OF EXPOSURE :
 
  Oral
  
 
  SPECIES OBSERVED :
 
  Rodent - mouse
  
 
  DOSE/DURATION :
 
  175 mg/kg
  
 
  TOXIC EFFECTS :
 
  Details of toxic effects not reported other than lethal dose value
  
 
  REFERENCE :
 
  SMWOAS Schweizerische Medizinische Wochenschrift. (Schwabe & Co., Steintorst 13, 4010 Basel, Switzerland) V.50- 1920- Volume(issue)/page/year: 90,213,1960
  
 
  TYPE OF TEST :
 
  LD50 - Lethal dose, 50 percent kill
  
 
  ROUTE OF EXPOSURE :
 
  Intraperitoneal
  
 
  SPECIES OBSERVED :
 
  Rodent - mouse
  
 
  DOSE/DURATION :
 
  150 mg/kg
  
 
  TOXIC EFFECTS :
 
  Details of toxic effects not reported other than lethal dose value
  
 
  REFERENCE :
 
  PHARAT Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- Volume(issue)/page/year: 27,520,1972
  
 
  TYPE OF TEST :
 
  LD50 - Lethal dose, 50 percent kill
  
 
  ROUTE OF EXPOSURE :
 
  Subcutaneous
  
 
  SPECIES OBSERVED :
 
  Rodent - mouse
  
 
  DOSE/DURATION :
 
  140 mg/kg
  
 
  TOXIC EFFECTS :
 
  Details of toxic effects not reported other than lethal dose value
  
 
  REFERENCE :
 
  DIPHAH Dissertationes Pharmaceuticae. (Warsaw, Poland) V.1-17, 1949-65. For publisher information, see PJPPAA. Volume(issue)/page/year: 8,289,1956
  
 
  TYPE OF TEST :
 
  LD50 - Lethal dose, 50 percent kill
  
 
  ROUTE OF EXPOSURE :
 
  Intravenous
  
 
  SPECIES OBSERVED :
 
  Rodent - mouse
  
 
  DOSE/DURATION :
 
  130 mg/kg
  
 
  TOXIC EFFECTS :
 
  Behavioral - rigidity (including catalepsy) Behavioral - muscle contraction or spasticity
  
 
  REFERENCE :
 
  THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 16,34,1961 *** REVIEWS *** TOXICOLOGY REVIEW AJMEAZ American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- Volume(issue)/page/year: 38,409,1965
  |